APA (7th ed.) Citation

Lisitsyna, T. A., Borisova, A. B., Reshetnyak, T. M., Veltishchev, D. Y., Diatroptov, M. E., Avdeeva, A. S., . . . Nasonov, E. L. (2025). Clinical significance of the determination of antibodies to the NR2 subunit of glutamate N-methyl-D-aspartate receptors (aNMDAR) in patients with systemic lupus erythematosus and antiphospholipid syndrome. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Lisitsyna, T. A., A. B. Borisova, T. M. Reshetnyak, D. Yu Veltishchev, M. E. Diatroptov, A. S. Avdeeva, K. S. Nurbaeva, A. A. Abramkin, and E. L. Nasonov. Clinical Significance of the Determination of Antibodies to the NR2 Subunit of Glutamate N-methyl-D-aspartate Receptors (aNMDAR) in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. IMA PRESS LLC, 2025.

MLA (9th ed.) Citation

Lisitsyna, T. A., et al. Clinical Significance of the Determination of Antibodies to the NR2 Subunit of Glutamate N-methyl-D-aspartate Receptors (aNMDAR) in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. IMA PRESS LLC, 2025.